News

Ideas That Generate Results

Global Biosimilars Market to Cross US$ 25 Billion by 2022

Sep 23, 2016

Share |
The global biosimilars market is expected to witness a steep growth owing to the patent expiry of blockbuster biologic drugs. The ability of biosimilars to reduce healthcare costs is another driving factor for this industry. Furthermore, the recent approval of three biosimilars in the US market is providing an impetus to more biopharmaceutical companies to enter this field.
 
According to our report, “Global Biosimilar Market Outlook 2022”, in the wake of the above developments the Global Biosimilars Market is expected to grow at a CAGR of around 40% from 2016 – 2022. The market segmentations by product type, by geography and by application have been mentioned in the report. The major types of biosimilars present in the market include monoclonal antibodies, erythropoietin, insulin, G-CSF, HGH, and interferon, amongst others.
 
Based on geography, the report divides the market into the Europe, Asia-Pacific, North America and Rest of the World. Furthermore, the global biosimilars market has also been segmented on the basis of their applications. According to the report, oncology is expected to account for the largest share in 2016 due to presence of large number of biosimilars for this indication. The report provides insight about the major drivers, challenges and opportunities, along with the latest trends and developments impacting the industry growth.
 
The mergers and acquisitions taking place in the biosimilar industry are highlighted in the report. The report also covers the key players of the Global Biosimilars Market. For every player, a brief business overview and key financials has been provided. The product portfolio, pipeline products and recent developments of each player have also been listed down. Overall, the research contains exhaustive information that will help clients in formulating market strategies and assessing opportunity areas in the Global Biosimilars Market.
 
Some of the key findings of the report are:
 
  • Biosimilars in US Driving Global Biosimilars Market Growth
 
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM857.htm
 
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm


Media Citation

get in touch

Please fill-in the information below.